TAK-505
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-505, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-505 in Adults With Solid Tumors [Phase 1, Phase 2]